UK markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
769.89-0.00 (-0.00%)
At close: 12:19PM EST
Sign in to post a message.
  • J
    JEFF
    Nio share price is now lower than Bidens approval rating. Don't get mad at me, I just report the news
  • Y
    Yahoo Finance Insights
    Bio-Rad Laboratories is down 4.96% to 744.35
  • Y
    Yahoo Finance Insights
    BIO-B is down 8.29% to 719.34
  • M
    MEHRAN
    why did it fall so much in the middle of the day?
  • N
    Norcalpanda
    Panic selling is good for this stock and LT investors.. keep buying more at this discounted price. It will be up 25-50 $ in a week.
  • J
    John K
    The market is due for a correction, probably of at least 10%. Myabe worse. The average S&P PE ratio is 39
    The historic average is about 16, so a really big drop could be round the corner, It will bring dowb all stocks, including BIO. I am waiting in cash to buy BIO in the dip.
  • j
    john
    I bought also some in 2016 and I believe in it.
  • A
    Anita
    I’m 57 and I want my booster!!!!!!!!
  • J
    John K
    Strong company in a growing market.
    Recent profits will not hold as covid declines.
    It has potential to produce vaccines to PREVENT CANCER
    Not a cure for cancer, but vaccines to prevent many forms of cancer.
    using Messenger RNA technology
    This would see the share price go through the roof.
  • O
    O-Behave
    $BIO is a gem. $BIIB just released great news and about to break out when eyes get on it. $BIIB beyond oversold
  • J
    John K
    The recent big ptofits were due to BIO supplying covid tests.
    So profits will fall as covid recedes,
    and the share price will probably fall,
    but once it settles this will be a great investment.
  • S
    Shorty McShortBear
    Went Long 225 shares of BIO at an average price of $598.77, yesterday. This is a short/medium term value/momentum/company quality play. I am looking for a 30-60% stock price gain over the next 30-60 days. I find this stock to be incredibly attractive in terms of risk/reward ratio. Downside risk from the $600 level appears almost nil to me.

    BIO is a leader in its field, with outstanding financials. very low P/E ratio, and huge growth potential going forward. I love the sector and see it only growing in coming years. Health Care and Life Sciences equipment are guaranteed to grow in demand on a worldwide level in coming years. BIO is a huge company, well-known throughout the entire First World as a leader in its field. I believe the company will thrive regardless of any economic headwinds the USA may experience in the next few years.

    I bypassed a lot of other companies offering opportunities for 100-500% stock price gains, due to the increased risk those stocks carry if they fail to deliver on a specific technology or product. BIO carries no such risk. I believe current Fair Value for BIO is over $700/share, and it should actually price well ahead of fair value based upon growth potential. I put almost my entire liquid asset cash savings into this stock yesterday in anticipation this will quickly move up to the $750-$850 level within the next 3-6 months.
  • B
    Brian
    Bought in at $136.50 back in June. 2016. Still in for the long haul.
  • J
    Jake
    Bio Rad Owns 8 billion in Investments. Anyone know what company they have 8 billion invested in?
  • S
    Sluggowski
    BioRad Powered by TipRanks

    Avg. Price Target
    $662.50

    28.25% Upside

    High $675.00
    30.67% Upside

    Low $650.00
    25.83% Upside

    In the last 3 months, 2 ranked analysts set 12-month price targets for BIO. The average price target among the analysts is $662.50. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price.
  • S
    Steve-382
    OK, I haven't looked at this company for years. Can someone give a quick explanation about the earnings trend over the last 4 years. Surely these numbers from Yahoo are incorrect.

    Diluted EPS - 126.20 58.27 11.94 3.82
  • R
    Robert Temple
    Why can’t a company like Bio-Rad produce tests for covid-19?
  • S
    Shorty McShortBear
    Sold my 225 shares at an average price of $627.10 for a small profit. Tired of waiting and I see better opportunities in Shorting stocks ahead of earnings as Irrational Exuberance drives stock prices up to even more unsustainable levels.

    Good Luck Folks! :-)
  • Y
    Yahoo Finance Insights
    Bio-Rad Laboratories reached an all time high at 545.97
  • N
    Neagu Matei
    is it down because of the vaccine news?